TALPHERA, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
TALPHERA, INC. (TLPH) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.96 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-02
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$1.43M, a 333.99% decline year-over-year.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$536.00K, a 114.83% decline year-over-year.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$1.84M, a 154.37% decline year-over-year.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$578.00K, a 109.96% decline year-over-year.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.81M, a 77.95% decline from fiscal 2015.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $8.20M.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$5.78M.
- TALPHERA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$6.92M, a 146.27% decline from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$1.96M 10-Q · filed 2017-08-02 | -$3.80M derived: sum of 3 quarters · filed 2017-08-02 | -$4.38M derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | -$536.00K 10-Q · filed 2017-05-08 | -$2.37M derived: sum of 2 quarters · filed 2017-05-08 | -$2.95M derived: sum of 3 quarters · filed 2017-05-08 | -$2.34M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$2.42M derived: sum of 2 quarters · filed 2017-03-03 | -$1.81M derived: sum of 3 quarters · filed 2017-08-02 | $1.81M 10-K · filed 2017-03-03 |
| 2016-09-30 | -$578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $31.00K derived: sum of 2 quarters · filed 2017-08-02 | $3.65M 10-Q · filed 2016-11-02 | $7.03M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-06-30 | $609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $4.22M 10-Q · filed 2017-08-02 | $7.60M derived: sum of 3 quarters · filed 2017-08-02 | $13.40M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | $3.62M 10-Q · filed 2017-05-08 | $6.99M derived: sum of 2 quarters · filed 2017-05-08 | $12.79M derived: sum of 3 quarters · filed 2017-05-08 | $12.33M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $9.18M derived: sum of 2 quarters · filed 2017-03-03 | $8.72M derived: sum of 3 quarters · filed 2017-03-03 | $8.20M 10-K · filed 2017-03-03 |
| 2015-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $5.34M derived: sum of 2 quarters · filed 2016-11-02 | $4.82M 10-Q · filed 2016-11-02 | $4.06M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$977.00K 10-Q · filed 2016-07-29 | -$1.74M derived: sum of 3 quarters · filed 2017-03-03 | -$5.29M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | -$514.00K 10-Q · filed 2016-05-02 | -$1.28M derived: sum of 2 quarters · filed 2017-03-03 | -$4.83M derived: sum of 3 quarters · filed 2017-03-03 | -$5.05M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$4.32M derived: sum of 2 quarters · filed 2017-03-03 | -$4.53M derived: sum of 3 quarters · filed 2017-03-03 | -$5.78M 10-K · filed 2017-03-03 |
| 2014-09-30 | -$3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$3.77M derived: sum of 2 quarters · filed 2015-11-03 | -$5.01M 10-Q · filed 2015-11-03 | -$7.09M derived: sum of 4 quarters · filed 2016-03-07 |
| 2014-06-30 | -$217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$1.46M 10-Q · filed 2015-08-04 | -$3.54M derived: sum of 3 quarters · filed 2016-03-07 | -$5.05M derived: sum of 4 quarters · filed 2016-03-07 |
| 2014-03-31 | -$1.24M 10-Q · filed 2015-05-05 | -$3.32M derived: sum of 2 quarters · filed 2016-03-07 | -$4.83M derived: sum of 3 quarters · filed 2016-03-07 | |
| 2013-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | -$3.59M derived: sum of 2 quarters · filed 2016-03-07 | -$6.92M 10-K · filed 2016-03-07 | |
| 2013-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$4.84M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$3.33M 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | $14.96M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |